A Productive Expression Platform Derived from Host-Restricted Eilat Virus: Its Extensive Validation and Novel...

Area of Science:

• Virology
• Molecular Biology
• Vaccinology

Background:

• Alphaviruses are mosquito-borne viruses with broad host ranges.
• Eilat virus (EILV) is unique due to its defect in vertebrate cell infection, offering a safety advantage.
• This characteristic makes EILV a promising candidate for developing novel expression vectors.

Purpose of the Study:

• To investigate the potential of Eilat virus (EILV) as a versatile expression platform.
• To engineer EILV-based vectors for expressing foreign genetic material and antigens.
• To develop a bivalent vaccine candidate using EILV recombinants.

Main Methods:

• Generated EILV chimeras by replacing structural genes with those from other alphaviruses.
• Assessed chimera rescue and titer in mosquito cells.
• Introduced foreign genetic materials into EILV via double subgenomic (SG) RNA vectors.
• Developed a bivalent vaccine candidate by inserting an additional SG promoter into a CHIKV-EILV chimera.

Main Results:

• Seven EILV-alphavirus chimeras were successfully rescued and produced high titers, indicating EILV's capacity to package diverse structural proteins.
• EILV vectors efficiently expressed four different foreign genetic materials of varying lengths.
• A bivalent vaccine candidate targeting Chikungunya virus (CHIKV) and Zika virus was successfully constructed.

Conclusions:

• The EILV genome demonstrates exceptional compatibility for genetic manipulation.
• EILV-based recombinants hold significant promise for the development of vaccines and diagnostic tools.
• Further research is necessary to fully explore the applications of these EILV-derived expression systems.